We are live on !
Find out more
McAdams Wright Ragen Portfolio holdings
AUM
$1.79B
Turnover
19.25%
1-Year Est. Return
13.95%
This Fund
S&P 500
This Quarter Est. Return
-0.99%
1 Year Est. Return
+13.95%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.79B
AUM Growth
-$285K
(-0.02%)
Cap. Flow
+$28.6M
Cap. Flow % of AUM
Cap. Flow %
1.6%
Top 10 Holdings %
Top 10 Hldgs %
25.41%
Holding
452
New
56
Increased
179
Reduced
158
Closed
31
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$34.4M |
| 2 |
Telefônica Brasil
VIV
|
+$19.8M |
| 3 |
AT&T
T
|
+$9.32M |
| 4 |
Rayonier Advanced Materials
RYAM
|
+$6.77M |
| 5 |
THORATEC CORPORATION
THOR
|
+$6.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Carnival Corporation Ltd
CCL
|
+$15.7M |
| 2 |
Apple
AAPL
|
+$10M |
| 3 |
F5
FFIV
|
+$7.93M |
| 4 |
Transocean
RIG
|
+$7.54M |
| 5 |
Intel
INTC
|
+$7.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.63% |
| 2 | Healthcare | 14.27% |
| 3 | Industrials | 12.52% |
| 4 | Real Estate | 9.66% |
| 5 | Energy | 9.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Elbit Systems
ESLT
$34.8B
| $994K | 0.06% |
16,025
+2,425
| +18% | +$148K |
2014 Q2
1 quarter
|
|
202
Clorox
CLX
$10.7B
| $942K | 0.05% |
9,809
+3,701
| +61% | +$335K |
2013 Q2
5 quarters
|
|
203
iShares Core S&P Mid-Cap ETF
IJH
$121B
| $942K | 0.05% |
34,465
+5,600
| +19% | +$158K |
2013 Q2
5 quarters
|
|
204
Medtronic
MDT
$124B
| $941K | 0.05% |
15,202
-2,150
| -12% | -$137K |
2013 Q2
5 quarters
|
|
205
PPG Industries
PPG
$25.1B
| $907K | 0.05% |
9,222
+6,814
| +283% | +$694K |
2013 Q3
4 quarters
|
|
206
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.2B
| $904K | 0.05% |
7,511
-2
| -0% | -$248 |
2013 Q2
5 quarters
|
|
207
DELISTED
Walgreens Boots Alliance
WBA
| $878K | 0.05% |
14,825
+1,001
| +7% | +$65.7K |
2013 Q2
5 quarters
|
|
208
ClearSign Technologies
CLIR
$16.7M
| $870K | 0.05% |
13,025
+6,835
| +110% | +$524K |
2014 Q2
1 quarter
|
|
209
Novartis
NVS
$297B
| $855K | 0.05% |
10,138
-107
| -1% | -$8.66K |
2013 Q2
5 quarters
|
|
210
DELISTED
Orange
ORAN
| $846K | 0.05% |
57,420
+2,805
| +5% | +$42.6K |
2013 Q2
5 quarters
|
|
211
Allstate
ALL
$65.5B
| $817K | 0.05% |
13,328
+6,659
| +100% | +$400K |
2013 Q3
4 quarters
|
|
212
M&T Bank
MTB
$32.2B
| $787K | 0.04% |
6,387
-5,854
| -48% | -$721K |
2013 Q2
5 quarters
|
|
213
Vanguard Morningstar Total Stock Market ETF
VTI
$687B
| $785K | 0.04% |
7,760
-250
| -3% | -$25.6K |
2013 Q2
5 quarters
|
|
214
Mondelez International
MDLZ
$83.2B
| $773K | 0.04% |
22,583
+3,651
| +19% | +$133K |
2013 Q2
5 quarters
|
|
215
Omeros
OMER
$1.22B
| $763K | 0.04% |
60,013
+2,500
| +4% | +$35K |
2013 Q2
5 quarters
|
|
216
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.4B
| $756K | 0.04% |
25,265
+5,359
| +27% | +$163K |
2014 Q2
1 quarter
|
|
217
Stryker
SYK
$118B
| $753K | 0.04% |
9,337
-798
| -8% | -$65.6K |
2013 Q2
5 quarters
|
|
218
Baxter International
BAX
$13.3B
| $752K | 0.04% |
19,312
+13,104
| +211% | +$532K |
2014 Q2
1 quarter
|
|
219
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$20.7B
| $747K | 0.04% |
15,139
+1,410
| +10% | +$70.3K |
2013 Q2
5 quarters
|
|
220
ArcelorMittal
MT
$45.3B
| $746K | 0.04% |
+23,835
| New | +$792K |
2014 Q3
0 quarters
|
|
221
abrdn Asia-Pacific Income Fund
FAX
$535M
| $735K | 0.04% |
20,784
+110
| +0.5% | +$4.04K |
2013 Q2
5 quarters
|
|
|
CELG
222
DELISTED
Celgene Corp
CELG
| $731K | 0.04% |
7,714
-1,718
| -18% | -$155K |
2013 Q2
5 quarters
|
|
223
Invesco QQQ Trust
QQQ
$475B
| $730K | 0.04% |
7,394
-99
| -1% | -$9.6K |
2013 Q2
5 quarters
|
|
224
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.87B
| $722K | 0.04% |
+72,000
| New | +$741K |
2014 Q3
0 quarters
|
|
225
Mechanics Bancorp
MCHB
$3.36B
| $707K | 0.04% |
41,405
+8,575
| +26% | +$153K |
2013 Q4
3 quarters
|
|
Similar funds
MGC
AWMDMG
NAM
KFS
McAdams Wright Ragen's Q3 2014 Portfolio in Review
As of Q3 2014, McAdams Wright Ragen held 452 positions worth $1.79B, down 0.02% from $1.79B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
McAdams Wright Ragen's Q3 2014 filing shows 56 new, 179 increased, 158 reduced and 31 closed positions. Its largest new stake was AbbVie: 620,414 shares worth $35.8M. The largest sale was Carnival Corporation Ltd, an estimated $15.7M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Industrials.
- McAdams Wright Ragen's largest Q3 2014 buy was AbbVie: 620,414 shares worth $35.8M.
- McAdams Wright Ragen added most to Telefônica Brasil in Q3 2014, an estimated $19.8M increase.
- McAdams Wright Ragen's biggest Q3 2014 reduction was Carnival Corporation Ltd, cutting an estimated $15.7M.
- McAdams Wright Ragen fully exited Timken Company in Q3 2014, selling an estimated $2.71M.
- McAdams Wright Ragen's ten largest holdings make up 25% of its $1.79B portfolio in Q3 2014.
- McAdams Wright Ragen opened 56 new positions and closed 31 in Q3 2014.
- McAdams Wright Ragen's portfolio value fell 0.02% quarter-over-quarter to $1.79B.
Based on McAdams Wright Ragen's 13F filing for Q3 2014, filed 14 Nov 2014.